CliffBio
small molecule

THIOLA EC

TIOPRONIN

Loss of exclusivityNovember 2038latest FDA-listed patent expiry
CompanyMISSION PHARMACAL CO

Drug detail

Brand nameTHIOLA EC
Active ingredientTIOPRONIN
Strength300MG
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2019
Marketing statusRX

Listed patents

PatentExpiresType
11458104November 2038use U-3441

Regulatory exclusivity

CodeExpires
ODE*June 2026

More from MISSION PHARMACAL CO

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

THIOLA EC patent cliff — loss of exclusivity November 2038 | CliffBio